Market Newsdesk

MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of InspireMD’s Board of Directors approved inducement grants to eight (8) new non-executive employees in the aggregate amount of 122,054 shares of restricted stock (the “Inducement Grants”) outside of InspireMD’s 2021 Equity Incentive Plan, with a grant date as of November 20, 2025, as an inducement material to the non-executive employees entering into employment with InspireMD, in accordance with Nasdaq Listing Rule 5635(c)(4).

The Inducement Grants were granted under the InspireMD’s 2024 Inducement Plan, which is used exclusively for the grant of equity awards to individuals who were not previously employees of InspireMD, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with InspireMD, pursuant to Nasdaq Listing Rule 5635(c)(4).

The restricted stock vests over a three-year period, with one-third vesting on the first anniversary of the grant and the remainder vesting in two equal installments on the second and third anniversaries of the grant date, subject to continued employment with InspireMD as of such vesting dates.

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on the Company’s website. For more information, please visit www.inspiremd.com.

Forward-looking Statements

This press release contains “forward-looking statements.” Forward-looking statements include, but are not limited to, statements regarding InspireMD or its management team’s expectations, hopes, beliefs, intentions or strategies regarding future events, future financial performance, strategies, expectations, competitive environment and regulation. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential”, “scheduled” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with the Company’s history of recurring losses and negative cash flows from operating activities, significant future commitments and the uncertainty regarding the adequacy of its liquidity to pursue its complete business objectives, and substantial doubt regarding its ability to continue as a going concern; the Company’s need to raise additional capital to meet its business requirements in the future and such capital raising may be costly or difficult to obtain and could dilute out stockholders’ ownership interests; the clinical development, commercialization and market acceptance of the Company’s products; whether the clinical trial results for the Company’s products will be predictive of real-world results; an inability to secure and maintain regulatory approvals for the sale of the Company’s products; negative clinical trial results or lengthy product delays in key markets; the Company’s ability to maintain compliance with the Nasdaq listing standards; the Company’s ability to generate significant revenues from its products; estimates of the Company’s expenses, future revenues, capital requirements and its needs for and ability to access sufficient additional financing, including any unexpected costs or delays in the ongoing commercial launch of its products; the Company’s dependence on a single manufacturing facility and its ability to comply with stringent manufacturing quality standards and to increase production as necessary; the risk that the data collected from the Company’s current and planned clinical trials may not be sufficient to demonstrate that its technology is an attractive alternative to other procedures and products; intense competition in the Company’s industry, with competitors having substantially greater financial, technological, research and development, regulatory and clinical, manufacturing, marketing and sales, distribution and personnel resources than it does; entry of new competitors and products and potential technological obsolescence of the Company’s products; inability to carry out research, development and commercialization plans; loss of a key customer or supplier; technical problems with the Company’s research and products and potential product liability claims; product malfunctions; price increases for supplies and components; whether access to the Company’s products is achieved in a commercially viable manner and whether its products receive adequate reimbursement by governmental and other third-party payers; the Company’s efforts to successfully obtain and maintain intellectual property protection covering its products, which may not be successful; adverse federal, state and local government regulation, in the United States, Europe or Israel and other foreign jurisdictions; the fact that the Company conducts business in multiple foreign jurisdictions, exposing it to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction; security, political and economic instability in the Middle East that could harm the Company’s business, including due to the current security situation in Israel; current or future unfavorable economic and market conditions and adverse developments with respect to financial institutions and associated liquidity risk; and changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements and the impact of such policies on the Company, its customers and suppliers, and the global economic environment. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Investor Contacts:

Webb Campbell
Gilmartin Group LLC
[email protected]
[email protected]

BOSTON, Nov. 21, 2025 (GLOBE NEWSWIRE) — Cabot Corporation (NYSE: CBT) today announced that it has appointed William (“Bill”) Masterson as senior vice president and president, Reinforcement Materials segment, effective November 21, 2025. Masterson succeeds Matthew Wood, who ceases to serve in this position and as an employee of the Company effective immediately.  

Wood’s departure from the Company is not due to any disagreement with the Company on any matter related to the Company’s business performance, operations, financial statements, internal controls, or auditors.

Masterson joined Cabot from WR Grace in 2011 and, throughout his tenure, has held a variety of leadership positions with increasing responsibility across the Company’s businesses. Most recently, he served as vice president, Global Business Operations for Carbon and Silica Technologies, where he had global responsibility for all specialty carbon, specialty compounds, fumed metal oxide and aerogel manufacturing facilities spanning multiple regions. In this role, Bill also had leadership responsibility for the product management, supply chain, and product line technology functions, driving critical initiatives to enhance efficiency, optimize performance, and support long-term growth. Prior to that, he was vice president and regional business director for the Americas in the specialty carbons and fumed metal oxides product lines, where he was responsible for all sales, marketing, and technical service activities to drive growth and profitability in these product lines. In addition to these leadership roles, Bill also had enterprise responsibility for our global commercial center of excellence. Masterson’s extensive experience managing complex global operations combined with deep expertise in commercial strategy, positions him well to advance Cabot’s objectives in his new role.

“Bill brings a strong and diverse background to his new role, with deep expertise in global business operations, commercial strategy, and a proven ability to lead complex organizations. Throughout his career at Cabot, he has demonstrated disciplined execution and a commitment to driving growth and operational excellence,” said Sean Keohane, president and chief executive officer of Cabot Corporation. “Bill will also have the support of a long-tenured, highly experienced team with decades of knowledge in Reinforcement Materials, providing consistency and strength as he leads the business forward. He is also highly regarded for his collaborative leadership style and his ability to develop talent across the Company. I am confident that his strategic insight and operational experience will position the Reinforcement Materials business for continued success and long-term growth.”

About Cabot Corporation

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com. The Company regularly posts important information on its website and encourages investors and potential investors to consult the Cabot website regularly.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot’s business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward looking statements, see “Risk Factors” in the Company’s Annual Report on Form 10-K.

PALO ALTO, CA, Nov. 21, 2025 (GLOBE NEWSWIRE) — Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a recognized leader in AI- powered video surveillance, security analytics and remote monitoring today announced the expansion of its remote monitoring capabilities with the launch of its first global guard center in Kolkata, India. This strategic initiative brings human-verified security operations in-house, enabling faster response times, stronger oversight, and scalable worldwide coverage.

Combining Advanced Security Analytics with Remote Guard Expertise

Cloudastructure’s platform combines advanced security analytics, including AI-powered video surveillance, with trained remote guards who monitor camera feeds around the clock. With the establishment of its own monitoring center, Cloudastructure gains greater control over verification protocols, escalation workflows, and real time intervention. The Company can also optimize staffing to align with periods when cognitive performance is strongest, local daylight hours in India, ensuring more accurate and effective threat response.

Strategic Benefits

• Scalable Global Infrastructure

Owning its guard center in India enables Cloudastructure to scale remote monitoring operations across regions more efficiently while reducing reliance on third-party providers and lowering associated costs.

• Differentiated Competitive Advantage

With in-house remote guards operating in time zones aligned to peak alertness, Cloudastructure delivers superior verification, fewer false alarms, and a more reliable deterrent than traditional models that depend on external providers.

• Cost Efficiency & Margin Improvement

By bringing remote guard operations in-house, Cloudastructure reduces outsourcing expenses, improves margin predictability, and reinforces its long-term profitability.

• Enhanced Investor Confidence

Control over critical security operations, combined with its powerful analytics platform, positions Cloudastructure as a truly vertically integrated leader in remote monitoring and proactive security. This integrated model strengthens the Company’s operational resilience and enhances the overall defensibility of its business.

“Opening our own guard center marks a major leap forward in how we deliver and scale remote monitoring, one of the fastest-growing segments of our business,” commented Cloudastructure CEO, James McCormick. “This facility in Kolkata is the first of what we believe will be many monitoring stations established outside the United States, and we are also evaluating the potential for a future U.S.-based center to further strengthen geographic coverage. With a proven 98% deterrence rate, our approach does more than react to threats, it predicts, verifies, and prevents them with exceptional accuracy. By aligning our guard teams to local daytime hours, we pair 21st-century AI security with peak human cognitive performance, ensuring the most proactive and reliable threat response in the industry.”

ABOUT CLOUDASTRUCTURE

Headquartered in Palo Alto, California, Cloudastructure’s advanced award-winning security platform utilizes a scalable cloud-based architecture that features cloud video surveillance with proprietary, state-of-the-art AI/ML analytics, and a seamless remote guarding solution. The combination enables enterprise businesses to achieve proactive, end-to-end security, and pairs that platform with an attractive value proposition that eschews proprietary hardware and offers contract-free, month-to-month pricing and unlimited 24/7 support. With Cloudastructure, companies can achieve unparalleled situational awareness in real time and thereby stop crime as it is happening, while simultaneously achieving up to a 75% lower Total Cost of Ownership than other systems. For more information, visit https://www.cloudastructure.com/.

Forward-Looking Statements

Certain statements in this press release may be considered forward-looking, such as statements containing estimates, projections, and other forward-looking information. Forward-looking statements are typically identified by words and phrases such as “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “seek,” “should,” “will,” “would,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target” or the negative of such words and other comparable terminology. However, the absence of these words does not mean that a statement is not forward-looking. Any forward-looking statement expressing an expectation or belief as to future events is expressed in good faith and believed to be reasonable at the time such forward-looking statement is made. However, these statements are not guarantees of future events and involve risks, uncertainties, and other factors beyond our control. Therefore, we caution you against relying on any of these forward-looking statements. Factors that could cause or contribute to such differences include the risks and uncertainties discussed in the reports that the Company has filed with the SEC, such as its Annual Report on Form 10-K. Actual outcomes and results may differ materially from what is expressed in any forward-looking statement. Except as required by applicable law, including U.S. federal securities laws, we do not intend to update any of the forward-looking statements to conform them to actual results or revised expectations.

Media Contact:

Kathleen Hannon
Sr. Communications Director
Cloudastructure, Inc.
[email protected].
(704) 574-3732

Investor Contact:

Crescendo Communications, LLC
212-671-1020
[email protected]